Phytoestrogen-derived multifunctional ligands for targeted therapy of breast cancer

Area of Science:

• Nanomedicine
• Pharmacology
• Oncology

Background:

• Estrogen receptors are overexpressed in breast tumors, making them a key target for drug delivery.
• Current nano-targeted delivery systems face challenges with ligand safety and effectiveness, hindering clinical use.
• Phytoestrogens offer potential as safe, estrogen receptor-binding ligands for targeted drug delivery.

Purpose of the Study:

• To investigate phytoestrogens as ligands for enhanced nano-targeted breast cancer drug delivery.
• To develop and evaluate a novel nanocomposite using modified tanshinone IIA and doxorubicin-loaded mesoporous silica nanoparticles.

Main Methods:

• Molecular docking was employed to identify tanshinone IIA (Tan IIA) as a suitable phytoestrogen ligand.
• Tan IIA was chemically modified to Tan-NH2, and then incorporated into doxorubicin-loaded mesoporous silica nanoparticles (Tan-Dox-MSN).
• In vitro and in vivo experiments assessed the nanocomposite's targeting ability, anti-tumor efficacy, and toxicity.

Main Results:

• Modified Tan IIA (Tan-NH2) demonstrated good biosafety, tumor targeting, and anti-metastasis effects.
• The developed Tan-Dox-MSN nanocomposite exhibited uniform particle size, high drug loading, and good dispersibility.
• Tan-Dox-MSN showed enhanced tumor targeting, superior anti-tumor activity, and reduced toxicity in normal organs compared to controls.

Conclusions:

• Phytoestrogens with high estrogen receptor affinity can significantly improve nano-targeted breast tumor therapy.
• The developed Tan-Dox-MSN nanocomposite represents a promising strategy for effective and safer breast cancer treatment.